Gateway 2012: Cambridge Major Laboratories - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Cambridge Major Laboratories


CAMBRIDGE MAJOR LABORATORIES – CRYSTALLIZATION AND SOLID STATE CHEMISTRY SERVICES

Cambridge Major Laboratories (CML) has established a new Center of Excellence for Crystallization and Solid State Chemistry in our Active Pharmaceutical Ingredient (API) development facilities in the Netherlands. Significant investments have been made in equipment and personnel as part of CML’s expansion into solid state services.

CML'S Solid State Chemistry Services

  • Crystallization Study – crystallize to obtain stable solids, for purification or isolation
  • Material Characterization – polymorph identification
  • Solubility Determination – in production solvents and buffer solutions
  • Salt Selection – suitable form selection
  • Polymorph Study – behavior in production solvents
  • Crystallization Process Development – combine optimal synthesis conditions with optimal crystallization conditions
  • Crystal Habit Optimization – control of particle size and shape

CML Overview

Analytical Services

API Manufacturing

Process Chemistry

Quality Assurance

Solid State Chemistry

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here